A. Goldstein and M. Badamchian, Thymosins: chemistry and biological properties in health and disease, Expert Opinion on Biological Therapy, vol.131, issue.1, pp.559-73, 2004.
DOI : 10.1016/S0165-5728(97)00189-6

E. Hannappel, beta-Thymosins, Annals of the New York Academy of Sciences, vol.43, issue.12, pp.21-37, 2007.
DOI : 10.1096/fj.01-0713com

C. Chen, M. Li, H. Yang, H. Chai, W. Fisher et al., Roles of Thymosins in Cancers and Other Organ Systems, World Journal of Surgery, vol.16, issue.3, pp.264-70, 2005.
DOI : 10.1007/s00268-004-7817-2

H. Gondo, J. Kudo, J. White, C. Barr, P. Selvanayagam et al., Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes, J Immunol, vol.139, issue.11, pp.3840-3848, 1987.

H. Cha, M. Jeong, and H. Kleinman, Role of Thymosin ??4 in Tumor Metastasis and Angiogenesis, CancerSpectrum Knowledge Environment, vol.95, issue.22, pp.1674-80, 2003.
DOI : 10.1093/jnci/djg100

D. Hose, J. Moreaux, T. Meissner, A. Seckinger, H. Goldschmidt et al., Induction of angiogenesis by normal and malignant plasma cells, Blood, vol.114, issue.1, 2009.
DOI : 10.1182/blood-2008-10-184226

URL : https://hal.archives-ouvertes.fr/inserm-00401390

D. Hose, T. Reme, T. Meissner, J. Moreaux, A. Seckinger et al., Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma Adjusting batch effects in microarray expression data using empirical Bayes methods, Blood Biostatistics, vol.1138, issue.101, pp.4331-40118, 2007.

J. Radl, Multiple myeloma and related disorders. Lessons from an animal model

L. Manning, J. Berger, O. Donoghue, H. Sheridan, G. Claringbold et al., A model of multiple myeloma: culture of 5T33 murine myeloma cells and evaluation of tumorigenicity in the C57BL/KaLwRij mouse, British Journal of Cancer, vol.66, issue.6, pp.109-141088, 1992.
DOI : 10.1038/bjc.1992.415

K. Breckpot, M. Dullaers, A. Bonehill, S. Van-meirvenne, C. Heirman et al., Lentivirally transduced dendritic cells as a tool for cancer immunotherapy, The Journal of Gene Medicine, vol.186, issue.8, pp.654-67, 2003.
DOI : 10.1002/jgm.400

J. Caers, E. Menu, H. De-raeve, D. Lepage, V. Valckenborgh et al., Antitumour and antiangiogenic effects of Aplidin in the 5TMM syngeneic models of multiple myeloma Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts, Br J Cancer Cancer Res, vol.9866, issue.162, pp.1966-74701, 2006.

A. Goldstein, Thymosin ??4: A New Molecular Target for Antitumor Strategies, CancerSpectrum Knowledge Environment, vol.95, issue.22, pp.1646-1653, 2003.
DOI : 10.1093/jnci/djg126

W. Wang, P. Chen, H. Hsiao, H. Wang, W. Liang et al., Overexpression of the thymosin ??-4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma, Oncogene, vol.23, issue.39, pp.6666-71, 2004.
DOI : 10.1038/sj.onc.1207888

W. Wang, P. Chen, H. Hsiao, S. Ju, Y. Su et al., Overexpression of the thymosin ??-4 gene is associated with malignant progression of SW480 colon cancer cells, Oncogene, vol.22, issue.21, pp.3297-306, 2003.
DOI : 10.1038/sj.onc.1206404

W. Leeanansaksiri, S. Desimone, T. Huff, E. Hannappel, and T. Huff, Thymosin??4 and Its N-Terminal Tetrapeptide, AcSDKP, Inhibit Proliferation, and Induce Dysplastic, Non-Apoptotic Nuclei and Degranulation of Mast Cells, Chemistry & Biodiversity, vol.1, issue.7, pp.1091-100, 2004.
DOI : 10.1002/cbdv.200490081

W. Huang, B. Wang, Q. Wang, F. Braet, M. Timmers et al., Thymosin beta4 and AcSDKP inhibit the proliferation of HL-60 cells and induce their differentiation and apoptosis The Factin content of multiple myeloma cells as a measure of their migration, Cell Biol Int Ann N Y Acad Sci, vol.30973, issue.6, pp.514-20124, 2002.

F. Xu and W. Saunders, Actin and Microtubules: Working Together to Control Spindle Polarity, Cancer Cell, vol.14, issue.3, pp.197-206, 2008.
DOI : 10.1016/j.ccr.2008.08.007

URL : http://doi.org/10.1016/j.ccr.2008.08.007